Chenghai Liu
Impact in
- Hepatology top 1%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacological Effects of Natural Compounds
Papers in
- Hepatology 68
- Liver physiology and pathology 48
- Liver Disease and Transplantation 15
- Epidemiology 41
- Liver Disease Diagnosis and Treatment 39
- Hepatitis B Virus Studies 8
- Co-authors
- Yanyan Tao (43 shared papers)Ping Liu (40 shared papers)Qinglan Wang (14 shared papers)Yuan Peng (22 shared papers)Yiyang Hu (17 shared papers)Mingyu Sun (10 shared papers)Li Shen (7 shared papers)Hongliang Liu (6 shared papers)
- Journals
- Journal of Ethnopharmacology (14 papers)Frontiers in Pharmacology (13 papers)Evidence-based Complementary and Alternative Medicine (9 papers)Chinese Journal of Integrative Medicine (6 papers)BMC Complementary and Alternative Medicine (4 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Chenghai Liu
153 papers receiving 2.9k citations
Chenghai Liu's Hit Papers
Peers
Comparison fields: 5 of 130
- Hepatology 821
- Pharmacology 541
- Complementary and alternative medicine 344
- Epidemiology 648
- Cancer Research 161
Countries citing papers authored by Chenghai Liu
This map shows the geographic impact of Chenghai Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenghai Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenghai Liu more than expected).
Fields of papers citing papers by Chenghai Liu
This network shows the impact of papers produced by Chenghai Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenghai Liu. The network helps show where Chenghai Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenghai Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Xiaozhang Tie Improves Intestinal Motility in Rats With Cirrhotic Ascites by Regulating the Stem Cell Factor/c-kit Pathway in Interstitial Cells of Cajal Hit paper breakdown → | 2020 | 265 |
| 2 | 2003 | 163 | |
| 3 | 2010 | 125 | |
| 4 | 2012 | 91 | |
| 5 | 2011 | 86 | |
| 6 | 2008 | 79 | |
| 7 | 2009 | 74 | |
| 8 | 2010 | 74 | |
| 9 | 2022 | 67 | |
| 10 | 2012 | 53 | |
| 11 | 2019 | 50 | |
| 12 | 2018 | 46 | |
| 13 | 2012 | 41 | |
| 14 | 2010 | 40 | |
| 15 | 2001 | 39 | |
| 16 | 2009 | 38 | |
| 17 | Effect of salvianolic acid B on collagen production and mitogen-activated protein kinase activity in rat hepatic stellate cells. | 2002 | 38 |
| 18 | 2012 | 37 | |
| 19 | 2014 | 36 | |
| 20 | 2014 | 36 |
About Chenghai Liu
Chenghai Liu is a scholar working on Hepatology, Epidemiology, Pharmacology, Molecular Biology and Complementary and alternative medicine, having authored 157 papers that have together received 2.9k indexed citations. Recurring topics across this work include Liver physiology and pathology (48 papers), Liver Disease Diagnosis and Treatment (39 papers), Drug-Induced Hepatotoxicity and Protection (20 papers), Liver Disease and Transplantation (15 papers), Traditional Chinese Medicine Analysis (10 papers), Pharmacological Effects of Natural Compounds (9 papers), Hepatitis B Virus Studies (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Hepatology (821 citations), Pharmacology (541 citations), Complementary and alternative medicine (344 citations), Epidemiology (648 citations) and Cancer Research (161 citations). Chenghai Liu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yanyan Tao, Ping Liu, Qinglan Wang, Yuan Peng, Yiyang Hu, Mingyu Sun, Li Shen, Hongliang Liu, Feng Xing and Qiang Zhao. Their work appears in journals such as Journal of Ethnopharmacology, Frontiers in Pharmacology, Evidence-based Complementary and Alternative Medicine, Chinese Journal of Integrative Medicine and BMC Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.